AxoGen, Inc. (AXGN) has a negative trailing P/E of -102.6, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 65.5 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -0.97%, forward earnings yield 1.53%. PEG 1.82.
Criteria proven by this page:
Overall SharesGrow Score: 52/100 with 3/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | -19.2 | 2.44 | 18.52 | 6.72 | - |
| 2017 | -90.3 | 2.65 | 37.45 | 15.61 | - |
| 2018 | -33.9 | -0.36 | 5.16 | 9.04 | - |
| 2019 | -24.1 | -1.03 | 5.31 | 6.58 | - |
| 2020 | -30.1 | 1.59 | 5.81 | 6.37 | - |
| 2021 | -14.3 | -1.72 | 3.43 | 3.03 | - |
| 2022 | -14.5 | -2.36 | 4.16 | 3.03 | - |
| 2023 | -13.5 | 0.52 | 3.06 | 1.84 | - |
| 2024 | -73.2 | 1.33 | 7.02 | 3.89 | - |
| 2025 | -96.0 | -2.01 | 11.70 | 6.69 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $-0.47 | $41.11M | $-14.41M | -35.1% |
| 2017 | $-0.31 | $60.43M | $-10.45M | -17.3% |
| 2018 | $-0.60 | $83.94M | $-22.4M | -26.7% |
| 2019 | $-0.74 | $106.71M | $-29.12M | -27.3% |
| 2020 | $-0.62 | $112.3M | $-24.8M | -22.1% |
| 2021 | $-0.68 | $127.36M | $-28.06M | -22% |
| 2022 | $-0.65 | $138.58M | $-27.34M | -19.7% |
| 2023 | $-0.51 | $159.01M | $-21.72M | -13.7% |
| 2024 | $-0.23 | $187.34M | $-9.96M | -5.3% |
| 2025 | $-0.34 | $225.21M | $-15.7M | -7% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $0.53 | $0.48 – $0.57 | $266.19M | $266.01M – $266.31M | 5 |
| 2027 | $0.76 | $0.68 – $0.83 | $310.65M | $305.72M – $316.47M | 5 |
| 2028 | $1.00 | $0.13 – $1.44 | $365.85M | $365.13M – $366.58M | 3 |
| 2029 | $1.31 | $1.29 – $1.32 | $425.03M | $421.17M – $429.56M | 1 |
| 2030 | $1.70 | $1.68 – $1.72 | $531.9M | $527.06M – $537.56M | 1 |
